The incidence of anaplastic large cell lymphoma (ALCL) has surged in recent years—possibly because of the growing use of textured breast implants. Considering this trend, some patients with breast cancer who undergo mastectomy may wonder if the benefits of getting reconstructive implants are worth the risk of developing a second cancer. A recent study published as a research letter by Kinslow et al in JAMA Network Open reported on the risk of breast ALCL in a population of women who have undergone implant reconstruction.
